Currently, the stock price of Alx Oncology Holdings Inc (ALXO) is $1.17. In the most recent trading session, the stock underwent a significant upswing, peaking at $3.0 after opening at $1.17. The stock touched a low of $1.0 before closing at $1.03.
In terms of market performance, Alx Oncology Holdings Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $2.59 on 08/26/24, while the lowest value was $0.40 on 06/27/25.
52-week price history of ALXO Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Alx Oncology Holdings Inc’s current trading price is -54.74% away from its 52-week high, while its distance from the 52-week low is 189.60%. The stock’s price range for this period has remained between $0.40 and $2.59. The Healthcare sector company’s shares managed to surpass a trading volume of around 2.86 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.86 million over the last three months.
Financial Performance and Market Capitalization
Alx Oncology Holdings Inc (ALXO) has experienced a quarterly rise of 144.31% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 62.65M and boasts a workforce of 80 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5426, with a change in price of +0.5470. Similarly, Alx Oncology Holdings Inc recorded 757,104 in trading volume during the last 100 days, posting a change of +87.80%.
ALXO Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ALXO stands at 0.25. Similarly, the long-term debt-to-equity ratio is also 0.17.
ALXO Stock Stochastic Average
As of today, the raw stochastic average of Alx Oncology Holdings Inc over the last 50 days is at 97.46%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 97.06%. Further, the company’s Stochastic %K and %D values for the last 20 days were 84.82% and 78.62%, respectively.
ALXO Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. This year’s metric has recorded a Price decrease of -53.39%. However, over the past six months, we’ve seen a weaker performance of 4.46%. The price of ALXO fallen by 116.67% over the last 30 days. And in the last five days, it has surged by 81.59%.
